ScreenerHero

SPAGOSpago Nanomedical AB (publ)

STO · SE · Healthcare · Biotechnology · spagonanomedical.se
0.1145SEK-4.58%Mkt Cap: 8.74M $P/E: —

Spago Nanomedical AB (publ), a clinical phase nanomedicine company, engages in the development of nanomedicines for cancer diagnostics and treatment primarily in Sweden. Its products include SpagoPix (SN132D), an MRI con…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$138.82BUSDP/E 31.9
REGN
Regeneron Pharmaceuticals, Inc.
$85.87BUSDP/E 20.5
ARGX
ARGENX SE
$61.34BUSDP/E 39.8
ARGX
argenx SE
$65.05BUSDP/E 39.6
MRNA
Moderna, Inc.
$57.94BUSD
UCB
UCB SA
$45.95BUSDP/E 19.6
RVMD
Revolution Medicines, Inc.
$44.89BUSD
ONC
BeOne Medicines AG
$42.36BUSDP/E 67.2
RPRX
Royalty Pharma Plc Class A
$35.43BUSDP/E 32.6
ALNY
Alnylam Pharmaceuticals, Inc.
$31.61BUSDP/E 41.2
BNTX
BioNTech SE
$29.28BUSD
INSM
Insmed Incorporated
$27.47BUSD
ROIV
Roivant Sciences Ltd. Common Shares
$26.22BUSD
INCY
Incyte Corporation
$25.91BUSDP/E 16.2
GMAB
Genmab A/S
$20.86BUSDP/E 26.3
GMAB
Genmab A/S
$19.26BUSDP/E 26.6
ASND
Ascendis Pharma A/S
$16.61BUSDP/E 19.6
JAZZ
Jazz Pharmaceuticals plc
$16.51BUSDP/E 17.4
BBIO
BridgeBio Pharma, Inc.
$15.93BUSD
EXEL
Exelixis, Inc.
$13.40BUSDP/E 17.0

Key Statistics

Company
Market Cap8.74M $
Enterprise Value4.14M $
Revenue (TTM)364.24K $
Gross Profit-1.06M $
Net Income (TTM)-2.54M $
Revenue/Share0.0011 USD
Last Price0.1145 SEK
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees7
CountrySE
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-2.29
PEG—
EV/EBITDA-1.65
EV/Revenue11.36
P/S24.01
P/B3.09
EPS (TTM)-0.06
EPS (Forward)—
52W Range
0.084211% of range0.3700
52W High0.3700 SEK
52W Low0.0842 SEK
Profitability
Gross Margin-2527.23%
Oper. Margin-736.68%
EBITDA Margin0.00%
Profit Margin-6076.43%
ROE-86.37%
ROA-72.39%
Growth
Revenue Growth-18.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF-2.71M $
CapEx (TTM)21.90K $
FCF Margin-408.89%
FCF Yield-17.03%
Net Debt-3.11M $
Net Debt/EBITDA1.24
Balance Sheet
Debt/Equity—
Current Ratio7.25
Quick Ratio6.44
Book Value/Sh0.0370 SEK
Cash/Share0.0490 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 SEK
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating0.0 (Hold)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)0.2650 SEK
Upside (mean)+131.4%
Target Range0.2650 SEK – 0.2650 SEK
# Analysts1
Ownership
Shares Out.798.38M
Float142.85M
Insiders70.07%
Institutions8.96%
Technical
SMA 500.1153 (-0.7%)
SMA 2000.1155 (-0.9%)
Beta—
S&P 52W Chg19.18%
Avg Vol (30d)332.58K
Avg Vol (10d)231.54K
Technical Indicators
RSI (14)48.3
MACD0.0004
MACD Signal0.0002
MACD Hist.+0.0002
BB Upper0.1198 SEK
BB Middle0.1156 SEK
BB Lower0.1114 SEK
BB Width7.25%
ATR (14)0.0079 SEK
Vol Ratio (20d)0.89x